<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is a rare <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome associated with an increased risk in <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0003812'>phenotypic variability</z:hpo> in BWS reflects its molecular <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This syndrome is a multigenic disorder caused by dysregulation of imprinted growth regulatory genes in the 11p15.5 region </plain></SENT>
<SENT sid="3" pm="."><plain>The most commonly reported <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> in this syndrome are <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> of embryologic origin such as <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms tumours</z:e>, <z:hpo ids='HP_0002884'>hepatoblastomas</z:hpo>, <z:hpo ids='HP_0003006'>neuroblastomas</z:hpo>, <z:hpo ids='HP_0002859'>rhabdomyosarcomas</z:hpo> and <z:hpo ids='HP_0006744'>adrenocortical carcinomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We report the case of a 10-year-old patient diagnosed with BWS, harbouring a CDKN1C (p57(KIP2)) mutation, who developed a T-type <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>To our knowledge it is the first report of an <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> of T-type in a child with BWS </plain></SENT>
<SENT sid="6" pm="."><plain>We discuss the possibility of a link between BWS and <z:mpath ids='MPATH_336'>leukaemia</z:mpath> via one of the few known negative regulator of hematopoiesis, the transforming growth factor beta pathway, depending upon the up-regulation of CDKN1C </plain></SENT>
</text></document>